Skip to main content
Marc Rothenberg, MD, Allergy & Immunology, Cincinnati, OH

Marc E Rothenberg MD

Pediatric Asthma & Allergic Conditions


Professor, Pediatrics, University of Cincinnati College of Medicine

Join to View Full Profile
  • 3333 Burnet Ave# MLC2000Cincinnati, OH 45229

  • Phone+1 513-636-6771

  • Fax+1 513-636-2511

Dr. Rothenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Boston Children’s Hospital
    Boston Children’s HospitalFellowship, Allergy and Immunology, 1992 - 1994
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1990 - 1992
  • Harvard Medical School
    Harvard Medical SchoolClass of 1990

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1997 - 2026
  • MA State Medical License
    MA State Medical License 1992 - 1997
  • Allergy & Immunology
    American Board of Allergy and Immunology Allergy & Immunology
  • Pediatrics
    American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2000
  • Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Genetic Variants at the 16p13 Locus Confer Risk for Eosinophilic Esophagitis  
    Robert P Kimberly, Marc E Rothenberg, Patrick M Gaffney, Hugh A Sampson, J Pablo Abonia, Mirna Chehade, Philip E Putnam, Brian P Vickery, Glenn T Furuta, John B Harley, Nature

Press Mentions

  • New ACG Guideline on EoE Reflects over a Decade of Advances in Diagnosis and Management
    New ACG Guideline on EoE Reflects over a Decade of Advances in Diagnosis and ManagementJanuary 22nd, 2025
  • In EoE, Esophageal Protein Profiles Appear Similar Between PPI-Responsive and Nonresponsive Patients Before Treatment
    In EoE, Esophageal Protein Profiles Appear Similar Between PPI-Responsive and Nonresponsive Patients Before TreatmentDecember 18th, 2024
  • Native American Children, Young Adults with Eosinophilic Esophagitis See Barriers in Care
    Native American Children, Young Adults with Eosinophilic Esophagitis See Barriers in CareOctober 15th, 2024
  • Join now to see all

Grant Support

  • Genetic and Immunological Dissection of Eosinophilic EsophagitisCINCINNATI CHILDRENS HOSP MED CTR2015–2026
  • Consortium of Eosinophilic Gastrointestinal Disease ResearchersCINCINNATI CHILDRENS HOSP MED CTR2014–2025
  • Regulation of Gastrointestinal EosinophilsCINCINNATI CHILDRENS HOSP MED CTR1999–2025
  • Regulation of Gastrointestinal EosinophilsCINCINNATI CHILDRENS HOSP MED CTR1999–2025
  • Regulation Of Gastrointestinal EosinophilsNational Institute Of Allergy And Infectious Diseases2010–2012
  • Role Of Desmoglein-1 In Eosinophilic EsophagitisNational Institute Of Allergy And Infectious Diseases2011
  • IL-13 And Eosinophilic EsophagitisNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • IL-13 Associated Eosinophil Lung ResponsesNational Institute Of Allergy And Infectious Diseases2010–2011
  • Eosinophilic Esophagitis And Food AllergyNational Institute Of Allergy And Infectious Diseases2010–2011
  • Epithelial-Derived Eotaxin 3 In Eosinophilic EsophagitisNational Institute Of Allergy And Infectious Diseases2010
  • A Multi-Center Clinical Trial Of 1760 MCG Of Daily Swallowed Fluticasone Vs. PlacNational Institute Of Allergy And Infectious Diseases2010
  • IL-13 Associated Eosinophil Lung ResponsesNational Institute Of Allergy And Infectious Diseases2009
  • A Multi-Center Clinical Trial Of 1760 MCG Of Daily Swallowed Fluticasone Vs. PlacNational Institute Of Allergy And Infectious Diseases2009
  • IL-13 And Eosinophilic EsophagitisNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
  • Epithelial-Derived Eotaxin 3 In Eosinophilic EsophagitisNational Institute Of Allergy And Infectious Diseases2006–2009
  • Clinical Trial: Effect Of Intravenous Anti-Il5 (MEPOLIZUMAB) In HypereosinophiliNational Center For Research Resources2008
  • Role Of Eotaxins And CCR3 In IL-13 Induced AsthmaNational Heart, Lung, And Blood Institute2004–2008
  • Core--Breeding And GenotypingNational Heart, Lung, And Blood Institute2004–2008
  • Effect Of Intravenous Anti-Il5 (MEPOLIZUMAB) In Hypereosinophilic SyndromesNational Center For Research Resources2005–2007
  • Eosinophil, Chemokine And IL-13 Cooperativity In AsthmaNational Institute Of Allergy And Infectious Diseases2004–2007
  • Role Of Arginase In Allergic Airway InflammationNational Institute Of Allergy And Infectious Diseases2003–2007
  • Anti-Il 5 For HypereosinophiliaFood And Drug Administration2005
  • IV Anti-Il5 (MEPOLIZUMAB) In Hypereosinophilic SyndromesNational Center For Research Resources2004
  • Mechanisms Of Eosinophilia In Experimental AsthmaNational Institute Of Allergy And Infectious Diseases1998–2002

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: